Please login to the form below

Not currently logged in
Email:
Password:

tolvaptan

This page shows the latest tolvaptan news and features for those working in and with pharma, biotech and healthcare.

Otsuka finally gets FDA OK for kidney disease drug

Otsuka finally gets FDA OK for kidney disease drug

At the second attempt, Otsuka has been given a green light in the US for tolvaptan, the first drug to be FDA-approved for polycystic kidney disease. ... Tolvaptan is a vasopressin V2-receptor antagonist designed to inhibit the formation, proliferation

Latest news

  • AZ, BMS and Boehringer among UK Prix Galien finalists AZ, BMS and Boehringer among UK Prix Galien finalists

    tolvaptan. Jinarc. Otsuka. Polycystic kidney disease. nintedanib. Ofev. Boehringer Ingelheim. Idiopathic pulmonary fibrosis.

  • New cancer meds and drug extensions top CHMP recommendations New cancer meds and drug extensions top CHMP recommendations

    The CHMP, the drug safety and efficacy arm of the EMA, has recommended approval for Otsuka's Jinarc (tolvaptan) for the treatment of patients with autosomal dominant polycystic kidney disease (ADPKD),

  • Jinarc backed for European approval in rare kidney disease Jinarc backed for European approval in rare kidney disease

    The European Medicines Agency has recommended granting a marketing authorisation to Otsuka's orphan drug Jinarc (tolvaptan). ... The CHMP says that while no cases of liver failure were found in Otsuka's latest trial, it “ is possible that in a wider

  • Otsuka launches European ADPKD forum Otsuka launches European ADPKD forum

    Otsuka's interests in the area include the treatment Samsca (tolvaptan), which was turned down last year by the FDA for use as an ADPKD treatment, but is approved in Japan

  • Japanese product news in brief Japanese product news in brief

    Otsuka has launched a 30mg tablet formulation of Samsca (tolvaptan), its drug to treat autosomal dominant polycystic kidney disease (ADPKD), which should make the therapy easier for patients to take. ... Tolvaptan is a first-in-class vasopressin

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics